Literature DB >> 19648278

The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9.

Eddie A James1, Antonis K Moustakas, John Bui, Randi Nouv, George K Papadopoulos, William W Kwok.   

Abstract

Peptide binding to class II MHC protein is commonly viewed as a combination of discrete anchor residue preferences for pockets 1, 4, 6/7, and 9. However, previous studies have suggested cooperative effects during the peptide binding process. Investigation of the DRB1*0901 binding motif demonstrated a clear interaction between peptide binding pockets 6 and 9. In agreement with prior studies, pockets 1 and 4 exhibited clear binding preferences. Previously uncharacterized pockets 6 and 7 accommodated a wide variety of residues. However, although it was previously reported that pocket 9 is completely permissive, several substitutions at this position were unable to bind. Structural modeling revealed a probable interaction between pockets 6 and 9 through beta9Lys. Additional binding studies with doubly substituted peptides confirmed that the amino acid bound within pocket 6 profoundly influences the binding preferences for pocket 9 of DRB1*0901, causing complete permissiveness of pocket 9 when a small polar residue is anchored in pocket 6 but accepting relatively few residues when a basic residue is anchored in pocket 6. The beta9Lys residue is unique to DR9 alleles. However, similar studies with doubly substituted peptides confirmed an analogous interaction effect for DRA1/B1*0301, a beta9Glu allele. Accounting for this interaction resulted in improved epitope prediction. These findings provide a structural explanation for observations that an amino acid in one pocket can influence binding elsewhere in the MHC class II peptide binding groove.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648278      PMCID: PMC4061985          DOI: 10.4049/jimmunol.0802228

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  MHC class II tetramers identify peptide-specific human CD4(+) T cells proliferating in response to influenza A antigen.

Authors:  E J Novak; A W Liu; G T Nepom; W W Kwok
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Mutational analysis of critical residues determining antigen presentation and activation of HLA-DQ0602 restricted T-cell clones.

Authors:  Sandra Reichstetter; George K Papadopoulos; Antonis K Moustakas; Eric Swanson; Andrew W Liu; Sucheta Beheray; Ruth A Ettinger; Gerald T Nepom; William W Kwok
Journal:  Hum Immunol       Date:  2002-03       Impact factor: 2.850

3.  Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens.

Authors:  E J Novak; A W Liu; J A Gebe; B A Falk; G T Nepom; D M Koelle; W W Kwok
Journal:  J Immunol       Date:  2001-06-01       Impact factor: 5.422

4.  Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.

Authors:  Chu-Young Kim; Hanne Quarsten; Elin Bergseng; Chaitan Khosla; Ludvig M Sollid
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

5.  Definition of the peptide binding motif within DRB1*1401 restricted epitopes by peptide competition and structural modeling.

Authors:  Eddie A James; Antonis K Moustakas; Deanna Berger; Laurie Huston; George K Papadopoulos; William W Kwok
Journal:  Mol Immunol       Date:  2008-02-13       Impact factor: 4.407

6.  Structures of an MHC class II molecule with covalently bound single peptides.

Authors:  D H Fremont; W A Hendrickson; P Marrack; J Kappler
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

7.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.

Authors:  P Ghosh; M Amaya; E Mellins; D C Wiley
Journal:  Nature       Date:  1995-11-30       Impact factor: 49.962

8.  HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.

Authors:  A Geluk; K E van Meijgaarden; S Southwood; C Oseroff; J W Drijfhout; R R de Vries; T H Ottenhoff; A Sette
Journal:  J Immunol       Date:  1994-06-15       Impact factor: 5.422

9.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.

Authors:  L J Stern; J H Brown; T S Jardetzky; J C Gorga; R G Urban; J L Strominger; D C Wiley
Journal:  Nature       Date:  1994-03-17       Impact factor: 49.962

10.  Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients.

Authors:  Satoshi Murao; Hideichi Makino; Yukikazu Kaino; Etsushi Konoue; Jun Ohashi; Kaichi Kida; Yasuhisa Fujii; Ikki Shimizu; Eiji Kawasaki; Masao Fujiyama; Shiori Kondo; Kiyonobu Tanaka; Yoshinao Tarumi; Isamu Seto; Kenichi Kato; Keizo Ohno; Yukiko Kusunoki; Osamu Ebisui; Yasuharu Takada; Katsuya Tanabe; Koji Takemoto; Hiroshi Onuma; Tatsuya Nishimiya; Haruhiko Osawa
Journal:  Diabetes       Date:  2004-10       Impact factor: 9.461

View more
  13 in total

1.  HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets.

Authors:  Eddie A James; Antonis K Moustakas; John Bui; George K Papadopoulos; George Bondinas; Jane H Buckner; William W Kwok
Journal:  Arthritis Rheum       Date:  2010-10

2.  Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.

Authors:  I-Ting Chow; Eddie A James; Theresa J Gates; Venus Tan; Antonis K Moustakas; George K Papadopoulos; William W Kwok
Journal:  J Immunol       Date:  2013-03-29       Impact factor: 5.422

3.  DRB1*12:01 presents a unique subset of epitopes by preferring aromatics in pocket 9.

Authors:  I-Ting Chow; Eddie A James; Venus Tan; Antonis K Moustakas; George K Papadopoulos; William W Kwok
Journal:  Mol Immunol       Date:  2011-12-23       Impact factor: 4.407

4.  FVIII proteins with a modified immunodominant T-cell epitope exhibit reduced immunogenicity and normal FVIII activity.

Authors:  Ruth A Ettinger; Joseph A Liberman; Devi Gunasekera; Komal Puranik; Eddie A James; Arthur R Thompson; Kathleen P Pratt
Journal:  Blood Adv       Date:  2018-02-27

5.  HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.

Authors:  Simon D van Haren; Eszter Herczenik; Anja ten Brinke; Koen Mertens; Jan Voorberg; Alexander B Meijer
Journal:  Mol Cell Proteomics       Date:  2011-04-05       Impact factor: 5.911

Review 6.  Current tools for predicting cancer-specific T cell immunity.

Authors:  David Gfeller; Michal Bassani-Sternberg; Julien Schmidt; Immanuel F Luescher
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

7.  Theoretical analysis of the neuraminidase epitope of the Mexican A H1N1 influenza strain, and experimental studies on its interaction with rabbit and human hosts.

Authors:  Paola Kinara Reyes Loyola; R Campos-Rodríguez; Martiniano Bello; S Rojas-Hernández; Mirko Zimic; Miguel Quiliano; Verónica Briz; M Angeles Muñoz-Fernández; Luis Tolentino-López; Jose Correa-Basurto
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

8.  Dynamically Driven Allostery in MHC Proteins: Peptide-Dependent Tuning of Class I MHC Global Flexibility.

Authors:  Cory M Ayres; Esam T Abualrous; Alistair Bailey; Christian Abraham; Lance M Hellman; Steven A Corcelli; Frank Noé; Tim Elliott; Brian M Baker
Journal:  Front Immunol       Date:  2019-05-03       Impact factor: 7.561

9.  Prediction of the binding affinities of peptides to class II MHC using a regularized thermodynamic model.

Authors:  Andrew J Bordner; Hans D Mittelmann
Journal:  BMC Bioinformatics       Date:  2010-01-20       Impact factor: 3.169

10.  Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study.

Authors:  Amit Kumar; Eleonora Cocco; Luigi Atzori; Maria Giovanna Marrosu; Enrico Pieroni
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.